Dermatology · Austin, TX
NPI
1407895253
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3807 Spicewood Springs Rd, Suite 200
Austin, TX, 78759
Phone (512) 476-9195
Groups this clinician bills Medicare through
Medicare paid, 2024
$184K
4,218 services
Medicare patients, 2024
943
Average age 75
Drug cost, 2024
$1.6M
1,578 prescriptions
Company payments, 2025
$201K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dale G Schaefer was code 17003 (destruction skin lesion), 1,487 times for 254 patients. In total Dale G Schaefer billed 4,218 services in 34 codes, and Medicare paid $184K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,487 | 254 | $5.45 | $8,098 |
| 99213 Office E&M - Established | Office | 879 | 625 | $64.76 | $57K |
| 17000 Destruction Skin Lesion | Office | 483 | 346 | $47.55 | $23K |
| 99212 Office E&M - Established | Office | 341 | 269 | $41.57 | $14K |
| 99214 Office E&M - Established | Office | 287 | 213 | $95.79 | $27K |
| 11102 Skin Biopsy | Office | 195 | 176 | $80.24 | $16K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 126 | 26 | $0.56 | $70.45 |
| 99203 Office E&M - New | Office | 89 | 89 | $74.99 | $6,674 |
| 96372 Injection Administration | Office | 63 | 33 | $10.41 | $656 |
| 17262 Destruction Skin Lesion | Office | 52 | 41 | $141.85 | $7,376 |
| 11103 Skin Biopsy | Office | 33 | 30 | $43.92 | $1,449 |
| 17004 Destruction Skin Lesion | Office | 22 | 18 | $133.65 | $2,940 |
| 99202 Office E&M - New | Office | 21 | 21 | $53.31 | $1,119 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 20 | 19 | $310.01 | $6,200 |
| 96567 Skin | Office | 20 | 19 | $111.17 | $2,223 |
By year: 2022 $223K for 6,270 services; 2023 $194K for 4,907 services; 2024 $184K for 4,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dale G Schaefer prescribed most often to Medicare patients was Minoxidil, with 219 prescriptions and refills. In total Dale G Schaefer wrote 1,578 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 219 | 573 | 89 | $1,453 |
| Doxycycline Hyclate Generic | 153 | 197 | 59 | $2,564 |
| Clobetasol Propionate Generic | 113 | 122 | 68 | $2,989 |
| Triamcinolone Acetonide Generic | 90 | 94 | 72 | $2,018 |
| Fluticasone Propionate Generic | 84 | 87 | 77 | $1,414 |
| Mupirocin Generic | 81 | 85 | 52 | $640 |
| Otezla Apremilast | 67 | 67 | Under 11 | $312K |
| Ketoconazole Generic | 57 | 61 | 30 | $1,349 |
| Metronidazole Generic | 56 | 69 | 33 | $2,678 |
| Valacyclovir Valacyclovir Hcl | 44 | 72 | 28 | $1,715 |
| Tacrolimus Generic | 34 | 34 | 20 | $3,495 |
| Terbinafine Hcl Generic | 33 | 38 | 22 | $169 |
| Clindamycin Phosphate Generic | 31 | 37 | 18 | $1,252 |
| Zoryve Roflumilast | 26 | 32 | Under 11 | $34K |
| Skyrizi Pen Risankizumab-Rzaa | 25 | 68 | Under 11 | $509K |
Brand drugs: 280 claims; generic drugs: 1,298 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dale G Schaefer $201K ($201K in general payments such as food, travel and fees) from 23 companies. The largest payer was Arcutis Biotherapeutics, Inc. with $76K.
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | 69 | $76K |
| Amgen Inc. AMGN | 72 | $70K |
| Organon LLC OGN | 20 | $21K |
| Abbvie Inc. ABBV | 62 | $18K |
| Janssen Biotech, Inc. JNJ | 37 | $15K |
| Genzyme Corporation SNY | 8 | $327 |
| Lilly USA, LLC LLY | 9 | $246 |
| UCB, Inc. UCB.BR | 9 | $234 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $198 |
| Galderma Laboratories, L.P. GALD.SW | 26 | $175 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.